HCW Biologics Inc. (HCWB) stock
HCWBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 6/3095% below fair value
$0.76−0.01 (-1.65%)
Close on Nov 18, 2026Market cap $1.40MP/E –Yield –
HCW Biologics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
HCW Biologics's price to sales ratio was 0.1× on Nov 11, 2026, against 7.8× a year earlier. Over the last 5 years it ranged from 0.1× to 24.6×, with a median of 7.6×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.1× | −3.5 |
| 2025 | Dec 31, 2025 | 3.6× | −1.2 |
| 2024 | Dec 31, 2024 | 4.7× | −10.6 |
| 2023 | Dec 29, 2023 | 15.4× | +2.6 |
| 2022 | Dec 30, 2022 | 12.7× | +6.5 |
| 2021 | Dec 31, 2021 | 6.2× | – |
See a number that looks wrong?